BioSpace News Archive

Therapeutic Solutions International announced today data on what the Company believes to be a novel procedure to enhance anti-inflammatory and regenerative activity of all mesenchymal stem cells.

Moderna, Inc. announced that with the assistance of the U.S. Government, it has entered into a Memorandum of Understanding with the Government of the Republic of Kenya to establish Kenya as the location for the Company’s mRNA manufacturing facility.

Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announced that an abstract for SBP-101, a proprietary polyamine analogue, has been accepted for poster presentation at the American Association for Cancer Research (AACR), which will be held April 8-13, 2022.

Reneo Pharmaceuticals, Inc. announced the appointments of Michael P. Cruse to the role of Chief Operating Officer and Jennifer P. Lam to the role of Principal Financial and Accounting Officer.

AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today announced that it will report full year 2021 financial results on Monday, March 14, 2022.

LAVATherapeuticsN.V.(Nasdaq:LVTX), an immuno-oncology company focused on developing its proprietary Gammabody™ platformof bispecific gamma delta T cell engagers (bsTCEs) to transform the treatment of cancer, today announced initial data from its first clinical study with LAVA-051.

Astellas Pharma Inc. today announced topline results from the Phase 3 SKYLIGHT 4™ clinical trial investigating the long-term safety of fezolinetant.

Q BioMed Inc. announced today that it has received a confirmed $500,000 order for Strontium Chloride USP Injections.

GlycoMantra has been granted worldwide, exclusive rights to a UMB technology to advance the company’s pipeline of therapeutics for treating drug-resistant metastatic colorectal cancer.

Alpha Tau Medical Ltd. announced today the successful closing of the previously announced business combination (the “Business Combination”).